Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,737
Closed -$148K 263
2025
Q4
$148K Buy
+11,737
New +$173K ﹤0.01% 246
2024
Q3
Sell
-53,496
Closed -$1.4M 391
2024
Q2
$1.4M Sell
53,496
-347,568
-87% -$7.23M 0.01% 290
2024
Q1
$8.77M Sell
401,064
-1,872
-0.5% -$40.1K 0.04% 256
2023
Q4
$9.37M Sell
402,936
-49,262
-11% -$991K 0.04% 264
2023
Q3
$8.92M Buy
452,198
+72,988
+19% +$1.44M 0.06% 266
2023
Q2
$8.6M Buy
379,210
+78,850
+26% +$1.59M 0.05% 278
2023
Q1
$5.9M Buy
300,360
+329
+0.1% +$6.32K 0.04% 290
2022
Q4
$5.16M Buy
+300,031
New +$5.32M 0.03% 292

Other funds holding RXO

Epoch Investment Partners's RXO Position: Q1 2026 in Review

Epoch Investment Partners sold out of RXO (RXO) in Q1 2026, closing a stake of 11,737 shares — an estimated $148K sold.

Epoch Investment Partners first reported a position in RXO in Q4 2022 and held it in 8 quarters. The position peaked at $9.37M in Q4 2023. 276 funds tracked by Wall St. Rank hold RXO as of Q1 2026.

  • Epoch Investment Partners reported no remaining RXO position as of Q1 2026 after selling out during the quarter.
  • Epoch Investment Partners sold 11,737 RXO shares in Q1 2026, an estimated $148K.
  • Epoch Investment Partners first reported a position in RXO in Q4 2022 and held it in 8 quarters.
  • Epoch Investment Partners's RXO position peaked at $9.37M in Q4 2023.
  • 276 funds tracked by Wall St. Rank held RXO as of Q1 2026.

Based on Epoch Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.